Literature DB >> 12827461

The cytopathic 18f strain of Hepatitis A virus induces RNA degradation in FrhK4 cells.

M Kulka1, A Chen, D Ngo, S S Bhattacharya, T A Cebula, B B Goswami.   

Abstract

The mechanism responsible for the induction of apoptosis by the rapidly replicating HM175/18f strain of Hepatitis A virus (HAV) was investigated. Full length HAV RNA and viral capsid protein VP1 were detected in 18f infected cells at earlier times post-infection than in HM175/clone 1 infected cells. Analysis of total cellular RNA from HM175/18f infected FrhK4 cells by denaturing agarose gel electrophoresis and Northern blot hybridization revealed extensive degradation of both the 28S and 18S ribosomal RNA (rRNA) molecules. Similar degradation was observed when these cells were infected with Human coxsackievirus B1, a fast replicating enterovirus. In contrast, the parental strain of 18f, HM175/clone 1 did not induce RNA degradation. Inhibition of RNA degradation correlated with inhibition of virus replication. The pattern of rRNA degradation resembled degradation of rRNAs by RNase L, an enzyme activated in interferon-treated cells following infection with certain viruses. Ribosomal RNA degradation was accompanied by the reduction in the levels of several cellular RNAs including those for beta-actin and glyceraldehyde-3-phosphate dehydrogenase, while the levels of c-myc and c-jun were higher. Interferon mRNAs could not be detected in either infected or mock-infected control cells, and STAT1, a key regulator of interferon action was not phosphorylated following virus infection. These results reveal a heretofore-undescribed pathway that involves the regulation of RNA degradation and apoptosis following HAV/18f replication in FrhK4 cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12827461      PMCID: PMC7086929          DOI: 10.1007/s00705-003-0110-0

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  7 in total

1.  The herpes simplex virus type 2 gene ICP10PK protects from apoptosis caused by nerve growth factor deprivation through inhibition of caspase-3 activation and XIAP up-regulation.

Authors:  Samantha Q Wales; Baiquan Li; Jennifer M Laing; Laure Aurelian
Journal:  J Neurochem       Date:  2007-10       Impact factor: 5.372

2.  Protease 3C of hepatitis A virus induces vacuolization of lysosomal/endosomal organelles and caspase-independent cell death.

Authors:  Andrey V Shubin; Ilya V Demidyuk; Nataliya A Lunina; Alexey A Komissarov; Marina P Roschina; Olga G Leonova; Sergey V Kostrov
Journal:  BMC Cell Biol       Date:  2015-02-27       Impact factor: 4.241

3.  Human Gut-On-A-Chip Supports Polarized Infection of Coxsackie B1 Virus In Vitro.

Authors:  Remi Villenave; Samantha Q Wales; Tiama Hamkins-Indik; Efstathia Papafragkou; James C Weaver; Thomas C Ferrante; Anthony Bahinski; Christopher A Elkins; Michael Kulka; Donald E Ingber
Journal:  PLoS One       Date:  2017-02-01       Impact factor: 3.240

4.  Development of a Real-Time Cell Analysis (RTCA) Method as a Fast and Accurate Method for Detecting Infectious Particles of the Adapted Strain of Hepatitis A Virus.

Authors:  Samuel Lebourgeois; Audrey Fraisse; Catherine Hennechart-Collette; Laurent Guillier; Sylvie Perelle; Sandra Martin-Latil
Journal:  Front Cell Infect Microbiol       Date:  2018-09-25       Impact factor: 5.293

5.  A microarray based approach for the identification of common foodborne viruses.

Authors:  Mobolanle Ayodeji; Michael Kulka; Scott A Jackson; Isha Patel; Mark Mammel; Thomas A Cebula; Biswendu B Goswami
Journal:  Open Virol J       Date:  2009-03-19

Review 6.  Molecular biology and inhibitors of hepatitis A virus.

Authors:  Yannick Debing; Johan Neyts; Hendrik Jan Thibaut
Journal:  Med Res Rev       Date:  2013-05-30       Impact factor: 12.944

7.  Apoptosis induced by a cytopathic hepatitis A virus is dependent on caspase activation following ribosomal RNA degradation but occurs in the absence of 2'-5' oligoadenylate synthetase.

Authors:  Biswendu B Goswami; Michael Kulka; Diana Ngo; Thomas A Cebula
Journal:  Antiviral Res       Date:  2004-09       Impact factor: 5.970

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.